[Progress in dermatology in 1973].
D000667:Ampicillin / Q000009:adverse effects; D002338:Carotenoids / Q000627:therapeutic use; D002722:Chlorobenzenes / Q000627:therapeutic use; D003880:Dermatology; D003875:Drug Eruptions / Q000209:etiology; D006801:Humans; D006827:Hydantoins / Q000009:adverse effects; D008545:Melanoma / Q000276:immunology; D008750:Methyldopa / Q000009:adverse effects; D009506:Nevus / Q000276:immunology; D009578:Nitrobenzenes / Q000627:therapeutic use; D011164:Porphyrias / Q000188:drug therapy; D011565:Psoriasis / Q000188:drug therapy; D012106:Research; D012871:Skin Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology; D012878:Skin Neoplasms / Q000276:immunology
D002722:Chlorobenzenes; D006827:Hydantoins; D009578:Nitrobenzenes; D002338:Carotenoids; D008750:Methyldopa; D000667:Ampicillin
Quelques acquisitions dermatologiques en 1973